Cargando…

Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients

INTRODUCTION: Mycophenolate mofetil (MMF), a new type of immunosuppressant, has emerged as a frontline agent for treating autoimmune diseases. Mycophenolic acid (MPA) is an active metabolite of MMF. MPA exposure varies greatly among individuals, which may lead to adverse drug reactions such as gastr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shu, Qing, Fan, Qingqing, Hua, Bingzhu, Liu, Hang, Wang, Shiying, Liu, Yunxing, Yao, Yao, Xie, Han, Ge, Weihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233479/
https://www.ncbi.nlm.nih.gov/pubmed/34188518
http://dx.doi.org/10.2147/PGPM.S295964
_version_ 1783713861200773120
author Shu, Qing
Fan, Qingqing
Hua, Bingzhu
Liu, Hang
Wang, Shiying
Liu, Yunxing
Yao, Yao
Xie, Han
Ge, Weihong
author_facet Shu, Qing
Fan, Qingqing
Hua, Bingzhu
Liu, Hang
Wang, Shiying
Liu, Yunxing
Yao, Yao
Xie, Han
Ge, Weihong
author_sort Shu, Qing
collection PubMed
description INTRODUCTION: Mycophenolate mofetil (MMF), a new type of immunosuppressant, has emerged as a frontline agent for treating autoimmune diseases. Mycophenolic acid (MPA) is an active metabolite of MMF. MPA exposure varies greatly among individuals, which may lead to adverse drug reactions such as gastrointestinal side effects, infection, and leukopenia. Genetic factors play an important role in the variation of MPA levels and its side effects. Although many published studies have focused on MMF use in patients after organ transplant, studies that examine the use of MMF in patients with autoimmune diseases are still lacking. METHODS: This study will not only explore the genetic factors affecting MPA levels and adverse reactions but also investigate the relationships between UGT1A9 −118(dT)9/10, UGT1A9 - 1818T>C, UGT2B7 802C>T, SLCO1B1 521T>C, SLCO1B3 334T>G, IMPDH1 −106G>A and MPA trough concentration (MPA C(0)), along with adverse reactions among Chinese patients with autoimmune diseases. A total of 120 patients with autoimmune diseases were recruited. The MPA trough concentration was detected using the enzyme multiplied immunoassay technique (EMIT). Genotyping was performed using a real-time polymerase chain reaction (PCR) system and validated allelic discrimination assays. Clinical data were collected for the determination of side effects. RESULTS: SLCO1B1 521T>C demonstrated a significant association with MPA C(0)/d (p=0.003), in which patients with the CC type showed a higher MPA C(0)/d than patients with the TT type (p=0.001) or the CT type (p=0.000). No significant differences were found in MPA C(0)/d among the other SNPs. IMPDH1 −106G>A was found to be significantly related to infections (p=0.006). Subgroup analysis revealed that UGT2B7 802C>T was significantly related to Pneumocystis carinii pneumonia infection (p=0.036), while SLCO1B1 521T>C was associated with anemia (p=0.029). CONCLUSION: For Chinese autoimmune disease patients, SLCO1B1 521T>C was correlated with MPA C(0)/d and anemia. IMPDH1 −106G>A was significantly related to infections. UGT2B7 802C>T was significantly related to Pneumocystis carinii pneumonia infection.
format Online
Article
Text
id pubmed-8233479
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82334792021-06-28 Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients Shu, Qing Fan, Qingqing Hua, Bingzhu Liu, Hang Wang, Shiying Liu, Yunxing Yao, Yao Xie, Han Ge, Weihong Pharmgenomics Pers Med Original Research INTRODUCTION: Mycophenolate mofetil (MMF), a new type of immunosuppressant, has emerged as a frontline agent for treating autoimmune diseases. Mycophenolic acid (MPA) is an active metabolite of MMF. MPA exposure varies greatly among individuals, which may lead to adverse drug reactions such as gastrointestinal side effects, infection, and leukopenia. Genetic factors play an important role in the variation of MPA levels and its side effects. Although many published studies have focused on MMF use in patients after organ transplant, studies that examine the use of MMF in patients with autoimmune diseases are still lacking. METHODS: This study will not only explore the genetic factors affecting MPA levels and adverse reactions but also investigate the relationships between UGT1A9 −118(dT)9/10, UGT1A9 - 1818T>C, UGT2B7 802C>T, SLCO1B1 521T>C, SLCO1B3 334T>G, IMPDH1 −106G>A and MPA trough concentration (MPA C(0)), along with adverse reactions among Chinese patients with autoimmune diseases. A total of 120 patients with autoimmune diseases were recruited. The MPA trough concentration was detected using the enzyme multiplied immunoassay technique (EMIT). Genotyping was performed using a real-time polymerase chain reaction (PCR) system and validated allelic discrimination assays. Clinical data were collected for the determination of side effects. RESULTS: SLCO1B1 521T>C demonstrated a significant association with MPA C(0)/d (p=0.003), in which patients with the CC type showed a higher MPA C(0)/d than patients with the TT type (p=0.001) or the CT type (p=0.000). No significant differences were found in MPA C(0)/d among the other SNPs. IMPDH1 −106G>A was found to be significantly related to infections (p=0.006). Subgroup analysis revealed that UGT2B7 802C>T was significantly related to Pneumocystis carinii pneumonia infection (p=0.036), while SLCO1B1 521T>C was associated with anemia (p=0.029). CONCLUSION: For Chinese autoimmune disease patients, SLCO1B1 521T>C was correlated with MPA C(0)/d and anemia. IMPDH1 −106G>A was significantly related to infections. UGT2B7 802C>T was significantly related to Pneumocystis carinii pneumonia infection. Dove 2021-06-21 /pmc/articles/PMC8233479/ /pubmed/34188518 http://dx.doi.org/10.2147/PGPM.S295964 Text en © 2021 Shu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Shu, Qing
Fan, Qingqing
Hua, Bingzhu
Liu, Hang
Wang, Shiying
Liu, Yunxing
Yao, Yao
Xie, Han
Ge, Weihong
Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients
title Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients
title_full Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients
title_fullStr Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients
title_full_unstemmed Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients
title_short Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients
title_sort influence of slco1b1 521t>c, ugt2b7 802c>t and impdh1 −106g>a genetic polymorphisms on mycophenolic acid levels and adverse reactions in chinese autoimmune disease patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233479/
https://www.ncbi.nlm.nih.gov/pubmed/34188518
http://dx.doi.org/10.2147/PGPM.S295964
work_keys_str_mv AT shuqing influenceofslco1b1521tcugt2b7802ctandimpdh1106gageneticpolymorphismsonmycophenolicacidlevelsandadversereactionsinchineseautoimmunediseasepatients
AT fanqingqing influenceofslco1b1521tcugt2b7802ctandimpdh1106gageneticpolymorphismsonmycophenolicacidlevelsandadversereactionsinchineseautoimmunediseasepatients
AT huabingzhu influenceofslco1b1521tcugt2b7802ctandimpdh1106gageneticpolymorphismsonmycophenolicacidlevelsandadversereactionsinchineseautoimmunediseasepatients
AT liuhang influenceofslco1b1521tcugt2b7802ctandimpdh1106gageneticpolymorphismsonmycophenolicacidlevelsandadversereactionsinchineseautoimmunediseasepatients
AT wangshiying influenceofslco1b1521tcugt2b7802ctandimpdh1106gageneticpolymorphismsonmycophenolicacidlevelsandadversereactionsinchineseautoimmunediseasepatients
AT liuyunxing influenceofslco1b1521tcugt2b7802ctandimpdh1106gageneticpolymorphismsonmycophenolicacidlevelsandadversereactionsinchineseautoimmunediseasepatients
AT yaoyao influenceofslco1b1521tcugt2b7802ctandimpdh1106gageneticpolymorphismsonmycophenolicacidlevelsandadversereactionsinchineseautoimmunediseasepatients
AT xiehan influenceofslco1b1521tcugt2b7802ctandimpdh1106gageneticpolymorphismsonmycophenolicacidlevelsandadversereactionsinchineseautoimmunediseasepatients
AT geweihong influenceofslco1b1521tcugt2b7802ctandimpdh1106gageneticpolymorphismsonmycophenolicacidlevelsandadversereactionsinchineseautoimmunediseasepatients